2017
DOI: 10.1080/15548627.2017.1360466
|View full text |Cite
|
Sign up to set email alerts
|

Astrocytes promote progression of breast cancer metastases to the brain via a KISS1-mediated autophagy

Abstract: Formation of metastases, also known as cancer dissemination, is an important stage of breast cancer (BrCa) development. KISS1 expression is associated with inhibition of metastases development. Recently we have demonstrated that BrCa metastases to the brain exhibit low levels of KISS1 expression at both mRNA and protein levels. By using multicolor immunofluorescence and coculture techniques here we show that normal adult astrocytes in the brain are capable of promoting metastatic transformation of circulating … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
27
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 45 publications
(28 citation statements)
references
References 59 publications
1
27
0
Order By: Relevance
“…In this regard, miR-345 was the only identified miR that directly targets KISS1, which is induced via the treatment of CXCL12 or CCL2 proteins [125][126][127]. They experimentally confirmed the binding of miR-345 in stably transfected KISS1 3'UTR in MDA231Br cells with astrocyte conditioned media treatment or in the presence of individual recombinant CCl2 or CXCL12 proteins [72]. Interestingly, the downregulation of KISS1 has a stimulating effect on ATG5 expression associated with autophagosome maturation.…”
Section: Crosstalk Of Cancer Cells With Brain Microenvironmentmentioning
confidence: 90%
See 1 more Smart Citation
“…In this regard, miR-345 was the only identified miR that directly targets KISS1, which is induced via the treatment of CXCL12 or CCL2 proteins [125][126][127]. They experimentally confirmed the binding of miR-345 in stably transfected KISS1 3'UTR in MDA231Br cells with astrocyte conditioned media treatment or in the presence of individual recombinant CCl2 or CXCL12 proteins [72]. Interestingly, the downregulation of KISS1 has a stimulating effect on ATG5 expression associated with autophagosome maturation.…”
Section: Crosstalk Of Cancer Cells With Brain Microenvironmentmentioning
confidence: 90%
“…MiR-122 reduces glucose consumption in stromal cells and allows more glucose to be accessible to cancer cells, hence facilitating the formation of the metastatic niche and cancer cell growth [74]. b CXCL12 or CCL2 secreted by astrocytes increases the level of miR-345 via CXCR4, which negatively regulates the expression of KISS1 and promotes invasion and survival in the brain [72]. c MiR-19a mediates the suppression of PTEN in cancer cells secreted by activated astrocytes.…”
Section: Mirnas and Metabolic Reprogramming In The Brain Microenvironmentioning
confidence: 99%
“…Though breast cancer exhibits good prognosis, some breast cancer patients still suffer tumor progression. One of the emerging concepts to promote progression of breast cancer is autophagy [4,[8][9][10][11]. It is now known that the dysregulation of autophagy promotes progression of breast cancer.…”
Section: Discussionmentioning
confidence: 99%
“…hypoxia, starvation) and helps sustain their survival [7]. It has been reported that autophagy promotes survival, proliferation, metastasis, and invasion of BC cells via regulating autophagy associated genes and non-coding RNAs [4,[8][9][10][11][12]. However, the underlying mechanisms, especially non-coding RNAs, in regulating autophagy of BC progression are not yet fully elucidated.…”
Section: Introductionmentioning
confidence: 99%
“…CXCL12 downregulates the expression of Kiss1 in breast cancer cells, a gene associated with metastasis inhibition. The expression of Kiss1 in human breast cancer specimens inversely correlates with levels of matrix metalloproteinase-9 (MMP-9) and IL-8—genes implicated in metastatic invasion [ 117 ]. CAFs have also been implicated in brain metastasis.…”
Section: The Role Of Cxcl12 and Cxcr4 In Breast Cancer Metastasismentioning
confidence: 99%